ICICI Bank's ex-CEO Chanda Kochhar held guilty of receiving Rs 64 crore bribe in Videocon loan case
In its order on July 3, the tribunal also upheld the Enforcement Directorate's attachment of properties in the matter, according to CNBC-TV18.
Chanda Kochhar had resigned from her post in October 2018 after questions were raised about a Rs 3,250-crore loan that the ICICI Bank had given the Videocon Group in 2012.
In January 2020, the Enforcement Directorate attached assets worth Rs 78 crore belonging to her and her husband, Deepak Kochhar. The action was reversed by the PMLA Adjudicating Authority in November 2020.
On July 3, the tribunal said that the day after the disbursement of the Rs 300 crore loan, Rs 64 crore was transferred by Videocon promoter VN Dhoot to NuPower Renewables, a company managed by Deepak Kochhar through Supreme Energy Private, reported CNBC-TV18.
It added that the allegations made by the Enforcement Directorate stand 'because on paper ownership of M/s NRPL [NuPower Renewables] is shown to be of VN Dhoot but according to him also, the entire control of the company was of Deepak Kochhar'.
During the proceedings, the Enforcement Directorate told the tribunal that Chanda Kochhar had failed to disclose a conflict of interest, CNBC reported. Accepting the central agency's submission, the tribunal said that the attached properties were proceeds of crime.
The order overturned an earlier clean chit that Chanda Kochhar received from a PMLA Adjudicating Authority.
In September 2020, Deepak Kochhar was arrested by the Enforcement Directorate and later released on bail.
In December 2022, the Central Bureau of Investigation had arrested the Kochhars, alleging that ICICI Bank, under the leadership of Chanda Kochhar, sanctioned a Rs 3,250-crore loan to companies owned by the Videocon Group in violation of the Banking Regulation Act, the Reserve Bank of India rules and the credit policies of the private sector bank.
In January 2023, the Bombay High Court ordered their release, saying that their arrests were not in accordance with the law. In February 2024, the High Court said that their arrest amounted to an abuse of power.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
4 minutes ago
- Economic Times
RBI grants AU Small Finance Bank a universal license, first in a decade
Synopsis The Reserve Bank of India has granted AU Small Finance Bank a universal banking license, the first in a decade, potentially paving the way for other small finance banks to transition. AU Bank met the RBI's stringent criteria, including minimum net worth, capital adequacy, and asset quality. PTI The Reserve Bank of India has granted universal banking licence to AU Small Finance Bank, making it the first ever such licence in a Bank, the biggest of the 11 small finance banks operating in the country, received the `in-principle' approval Thursday, a step to be considered a milestone in its journey. This opens the door for other small banks for a transition into big banks. Ujjivan Small Finance Bank and Jana Small Finance Bank already applied for the coveted licence. The last time RBI granted universal banking license to Bandhan Bank and IDFC Bank (now IDFC First Bank) was in April 2014. According to the central bank guidelines, listed small finance banks with minimum net worth of Rs 1,000 crore at the end of the previous quarter are eligible to apply for a transition. They also need to have a minimum 15% capital to risk-weighted assets ratio and net profits in the preceding two financial years. Their gross non-performing assets has to be less than or equal to 3% for two preceding financial years while the net non-performing assets has to be less than or equal to 1% for two preceding financial years. A transition into a universal lender, AU Bank's capital adequacy requirement would come down from 15% while the priority sector lending target would be lower at 40% instead of 60%. Then the norm of having at least 50% of the loan portfolio in loans less than Rs 25 lakh would also not apply.
Economic Times
4 minutes ago
- Economic Times
Global Health Q1 Results: Profit surges 50% to Rs 159 crore
The mutual fund industry experienced strong growth in new Systematic Investment Plan (SIP) registrations, with 1.67 crore accounts added in the quarter ended June 2025, driven by resilient retail participation despite market volatility. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads The mutual fund industry experienced strong growth in new Systematic Investment Plan (SIP) registrations, with 1.67 crore accounts added in the quarter ended June 2025, driven by resilient retail participation despite market volatility This was significantly higher than the 1.41 crore registrations in the previous quarter, according to data from the Association of Mutual Funds in India (AMFI).Groww emerged as the market leader , adding over 41.9 lakh new SIPs during the quarter, commanding a market share of 25 per June alone, Groww registered 15.7 lakh new SIPs, making it the highest monthly addition by any distributor in the segment. In value terms, new SIPs registered on the Groww platform during the June quarter stood at Rs 1,116 crore, marking a sharp 32 per cent growth over the previous One, the second-largest contributor, added 15 lakh new SIPs during the quarter. Among traditional distributors, NJ IndiaInvest added 5.9 lakh, while SBI and HDFC Securities recorded 4.3 lakh and 3.8 lakh new SIPs, respectively. PhonePe, another digital-first platform, added approximately 5.9 lakh SIPs, largely concentrated in lower-ticket surge in SIP additions came despite continued volatility in the equity markets, with the benchmark Nifty 50 delivering mid-single-digit returns retail investor interest in mutual funds remained strong. The industry saw total SIP inflows touch a record Rs 27,269 crore in June 2025, continuing a steady month-on-month rise. SIP assets under management (AUM) stood at Rs 15.3 lakh crore as of June 30, 2025, up from Rs 12.4 lakh crore a year to market experts, retail investors are increasingly viewing mutual funds as a tool for long-term wealth creation, indicating a shift from traditional savings to a more investment-oriented platforms have further improved accessibility and convenience for a broader base of investors. Additionally, investor education and awareness initiatives by AMFI and asset management companies (AMCs) have played a key role in promoting systematic investing and strengthening trust in the mutual fund ecosystem, they number of unique mutual fund investors in India grew to 5.4 crore in 2025, a 20 per cent rise from 4.5 crore in 2024 and a 42 per cent jump from 3.8 crore in industry's total assets under management (AUM) reached a record Rs 74.4 lakh crore in June 2025, marking an 18 per cent increase from Rs 63.2 lakh crore in the previous quarter.
Business Standard
4 minutes ago
- Business Standard
Artemis Medicare Services Ltd Reports Robust Q1 FY26 Results with 28.2% Growth in Net Profit
VMPL Gurugram (Haryana) [India], August 7: Artemis Medicare Services Ltd. has announced robust performance for Q1 for financial year 2025-26, with a consolidated gross revenue of ₹2,681 million for Q1, an upturn of 14.4% year on year. The Board of Directors were pleased to have approved the financial results for the quarter ended June 30, 2025, showing steady performance on all metrics. The company's net revenue from operations went up by 14.2% to ₹2,550 million from ₹2,232 million in the first quarter of FY25. The company's EBITDA went up 19.0% to ₹483 million, with a good margin of 19.0%. Most importantly, net profit jumped 28.2% to ₹212 million, up from ₹165 million in the same quarter last year. Quarterly Artemis Hospital Gurgaon Performance Highlights Q1 FY2025-26 (Apr-Jun) vs Q1 FY2024-25 * Average gross revenue per occupied bed (ARPOB) was at Rs 83,900, as against Rs 79,200 * Net Revenue from operations was up 16.0% to close at Rs 2,412 Million, as against Rs 2,080 Million in Q1 FY25 * EBITDA reported was Rs 495 Million at a margin of 20.5%, as against Rs 415 Million * Bed capacity utilisation stood at 61.2% * Revenues from overseas patients increased by 31.4% to Rs 704 Million from Rs 536 Million * Overseas patients contributed 29% to Net Revenue * Average length of stay (ALOS) at 3.7 days compared to 3.6 days Quarterly Consolidated Performance Highlights Q1 FY2025-26 (Apr-Jun) vs Q1 FY2024-25 * Net Revenue from operations was up 14.2% to close at Rs 2,550 Million, as against Rs 2,232 Million in Q1 FY25 * EBITDA reported was Rs 483 Million at a margin of 19.0%, as against Rs 406 Million * Net profit for Q1 closed at Rs 212 Million, as against Rs 165 Million in the Q1 FY25 Artemis Hospital in Gurgaon also delivered impressive results. The hospital's net income went up 16.0% to ₹2,412 million. The average revenue per occupied bed (ARPOB) went up to ₹83,900, the highest it has ever been. In Q1 FY25, it was ₹79,200. EBITDA for the hospital went up to ₹495 million, keeping a margin of 20.5%. Overseas sales were a big part of this, going up by 31.4% to ₹704 million, which is 29% of net sales. The average length of stay (ALOS) was 3.7 days, and 61.2% of the beds were full. Commenting on the company's performance, Onkar Kanwar, Chairman, Artemis Medicare Services Ltd said "We are pleased to announce a strong start to FY26, with Q1 delivering consistent growth and resilient operational performance despite being a seasonally soft quarter. Our continued focus on cost optimization, operational efficiency, and disciplined execution has enabled us to maintain healthy profitability and margins. Our highest-ever ARPOB, driven by an optimized case and payer mix and strong international patient inflow, reinforces our position as a leader in Medical Value Travel. During the quarter, we added new beds at our flagship hospital's third tower, strengthening capacity and improving unit economics in the coming quarters. We also signed a binding MoU with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre for a proposed Medical Services Agreement, marking an important step in expanding in North India. On the clinical front, we launched India's first private Geriatrics & Longevity Department and partnered with KIMS, Hyderabad for heart-lung transplants, underscoring our commitment to advanced patient-centric care. Looking ahead, we remain focused on sustainable growth through operational excellence, geographic expansion and strategic partnerships, as we continue building Artemis into one of India's most trusted healthcare brands."
